ARIUS Research Signs Anti-Cancer Antibody Discovery Deal with Takeda
Three-Year Collaboration to look for Novel Cancer Treatments
06-Apr-2006 -
ARIUS Research Inc. and Takeda Pharmaceutical Company Limited (Takeda) have entered into a three-year, multi-product collaboration using ARIUS' FunctionFIRST(TM) Platform to discover novel treatments for human disease.
Under the terms of the agreement, ARIUS will receive an upfront technology ...
milestone payments
Takeda
Takeda Pharmaceuticals